Advances in Clinical and Experimental Medicine
Title abbreviation: Adv Clin Exp MedJCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)Journal Citation Indicator (JCI) (2023) – 0.4Scopus CiteScore – 3.7 (CiteScore Tracker – 4.1)Index Copernicus – 171.00; MNiSW – 70 ptsISSN 1899–5276 (print)ISSN 2451-2680 (online)Periodicity – monthly
Editorial Article
Cellular and Intercellular Signaling in Rheumatoid Arthritis – New Therapeutic Targets
Jacek Szechiński, Magdalena Szmyrka−Kaczmarek, Beata Gruszecka
379-386
Original Article
Side Effects of Methotrexate Treatment in Patients With Rheumatoid Arthritis
Jerzy Świerkot, Jacek Szechiński
387-394
Serum and Synovial Fluid Nitrite Levels in Patients With Rheumatoid Arthritis and Osteoarthritis
Krzysztof Borysewicz, Ewa Seweryn, Magdalena Szmyrka−Kaczmarek, Jacek Szechiński, Teresa Banaś
395-398
Activation of STAT−1, −3, and −6 Proteins in Early Arthritis
Magdalena A. Sokalska−Jurkiewicz, Marta Madej, Beata Nowak, Anna Czarny, Ewa Zaczyńska, Piotr Wiland
399-404
The Activity of STAT−3 in Patients With Rheumatoid Arthritis
Marta Madej, Magdalena Sokalska−Jurkiewicz, Beata Nowak, Anna Czarny, Ewa Zaczyńska, Piotr Wiland
405-409
Serum Levels of Soluble Fas in Rheumatoid Arthritis Patients Treated With Infliximab
Magdalena Szmyrka−Kaczmarek, Piotr Wiland, Jacek Szechiński
411-414
iNOS Expression in Peripheral Blood Leukocytes of Patients With Early Arthritis and Established Rheumatoid Arthritis
Beata Nowak, Magdalena Sokalska−Jurkiewicz, Marta Madej, Ewa Zaczyńska, Anna Czarny, Jacek Szechiński
415-421
Review Article
Pharmacotherapy of Rheumatic Diseases in Pregnancy
Ewa Jaźwińska−Tarnawska, Przemysław Niewiński
423-431
Perspectives of Systemic Lupus Erythematosus Therapy
Krzysztof Borysewicz
433-439
Immunological Aspects of Systemic Sclerosis and New Strategies in Therapy
Ewa Morgiel, Joanna Krywejko, Piotr Wiland
441-446
The Role of Jak/STAT Signaling in Rheumatoid Arthritis
Piotr Wiland, Magdalena Sokalska−Jurkiewicz, Marta Madej
447-452
Optimization of Rheumatoid Diseases Therapy
Anna Wiela−Hojeńska
453-461
The Role of a Pharmacist in Rheumatoid Diseases Therapy
Łukasz Łapiński
463-469
The Influence of Rheumatoid Diseases Pharmacotherapy on Laboratory Findings
Magdalena Hurkacz, Anna Wiela−Hojeńska
471-478
Jak3 – Its Significance in Inflammatory Diseases of Joints – New Perspectives for Therapy
Joanna Krywejko, Ewa Morgiel, Piotr Wiland
479-484